The paradigm for treating people with obesity has often been to recommend lifestyle changes, and then if they develop diabetes or another metabolic condition, to treat them with metformin, insulin, or GLP-1 drugs, says study senior and corresponding author Andrew Stokes, associate professor of global health
If you take insulin or sulfonylureas alongside Ozempic, you may need closer blood glucose monitoring when restarting, as there could be an increased risk of hypoglycaemia
Studies have shown that patients taking Tirzepatide weekly for 72 weeks can expect to lose between 15% and 22.5% of their body weight
Yes, telehealth programs provide clinician assessment, lab testing coordination, and prescription delivery in many states
Those who meet these criteria may see significant health improvements and a reduction in the risks associated with obesity and related conditions